Guardant Health
GH
#2480
Rank
HK$45.23 B
Marketcap
HK$366.07
Share price
-5.93%
Change (1 day)
113.53%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

Guardant Health (GH) - Cash on Hand

Cash on Hand as of September 2024 : HK$7.78 Billion

According to Guardant Health 's latest financial reports the company has HK$7.78 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Guardant Health - Cash on Hand chart (from 2017 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31HK$9.12 B15.52%
2022-12-31HK$7.90 B8.63%
2021-12-31HK$7.27 B-47.73%
2020-12-31HK$13.91 B241.74%
2019-12-31HK$4.07 B24.1%
2018-12-31HK$3.28 B89.74%
2017-12-31HK$1.72 B134.09%
2016-12-31HK$0.73 B

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
HK$7.18 B-7.68%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$1.09 B-85.96%๐Ÿ‡บ๐Ÿ‡ธ USA